SightLine, which was founded in 1994 at the Matam incubator in Haifa, has raised $16.5 million to date.
Last year, the US Food and Drug Administration (FDA) approved for production and marketing the company's flagship product, ColonoSight, a colonoscope. Unlike other products on the market, ColonoSight does not use fiber optics for colonoscopy, but an integrated LED light source and miniature video camera.
SightLine's two other products, ProctoSight and RectoSight, have both obtained FDA and EU-CE Mark approval, and are sold in the US, Europe, and the Far East.
SightLine's fourth product, ThimbleCam, is a miniature patented fingertip-mounted video camera for diagnostic or surgical endoscopic procedures. The camera, which has an integrated LED light source, enables doctors to see any place in the body reachable by the finger. It is designed for gynaecologists and proctologists. ThimbleCam has CE Mark approval.
The funds raised, will be applied towards bringing the company from the product development stage to marketing and sales.
Israeli start-up SightLine Technologies Ltd. recently completed a $10 million financing round. NGN Capital, an American venture capital fund, along with SightLine's existing investors, participated in the round.